C&L-luettelon tietokanta
C&L-luettelon tietokanta
C&L-luettelon tietokanta
Tämä tietokanta sisältää valmistajilta ja maahantuojilta saatuja luokitus- ja merkintätietoja ilmoitetuista ja rekisteröidyistä aineista. Se sisältää myös yhdenmukaistettujen luokitusten luettelon. Tietokantaa päivitetään säännöllisesti uusin ja ajantasaistetuin ilmoituksin. Päivitettyjä ilmoituksia ei kuitenkaan voida merkitä nimenomaisesti, koska samalla tavalla luokitellut ilmoitukset kootaan yhteen näyttämistä varten.
REACH-rekisteröintimenettelyssä tietojen yhteistoimituksesta johdetut luokitukset on myös merkitty vastaavasti. Lisätietoja näistä aineista saa rekisteröityjen aineiden tietokannasta.
Huomaa, että jotkin tiedot luokitusten ja merkintöjen luettelosta voivat kuulua kolmansille osapuolille. Siksi kyseisten tietojen käyttö saattaa edellyttää ennakkolupaa kolmantena osapuolena olevilta haltijoilta. Tutustu oikeudelliseen huomautukseen saadaksesi isätietoja.
CL Inventory
Notifications submitted/updated by: 26 April 2024
Classification | Source | ||||
---|---|---|---|---|---|
Antimony, compound with manganese (1:1)
|
234-779-5 | 12032-82-5 |
|
Notified C&L | View details |
(±)-N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamide monohydrochloride
|
277-629-4 | 73899-76-0 |
|
Notified C&L | View details |
4-nitrophenyl β-D-glucopyranoside
|
219-661-3 | 2492-87-7 |
Not Classified
|
Notified C&L | View details |
(E)-3{(S)-1-[2-(2-amino-6-hydroxy-purin-9-ylmethoxy)-ethoxicarbonyl]-2-methyl-propylamino}-but-2-enoic acid methyl ester
|
606-477-7 | 202601-67-0 |
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L | View details |
5,6-diethylindan-2-aminium chloride
|
455-940-8 |
Acute Tox. 4
Skin Sens. 1
Eye Dam. 1
Aquatic Chronic 2
|
Notified C&L | View details | |
2,4,7-trinitrofluoren-9-one
|
204-965-0 | 129-79-3 |
Eye Irrit. 2
|
Notified C&L | View details |
Propanamide, N-[2-(4-phenoxyphenoxy)ethyl]-
|
600-606-0 | 104825-66-3 |
Aquatic Chronic 2
|
REACH registration C&L | View details |
Pentamidine
|
202-841-0 | 100-33-4 |
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2A
STOT SE 3
|
Notified C&L | View details |
4-amino-6-[[4-[[4-[[4-(diethylamino)-2-hydroxyphenyl]azo]phenyl]amino]-3-sulphophenyl]azo]-5-hydroxy-3-[(4-nitrophenyl)azo]naphthalene-2,7-disulphonic acid, sodium salt
|
303-569-6 | 94200-89-2 |
Not Classified
|
Notified C&L | View details |
Lubiprostone
|
603-977-7 | 136790-76-6 |
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
STOT SE 3
|
Notified C&L | View details |
2-ethyltoluene
|
210-255-1 | 611-14-3 |
Flam. Liq. 3
Eye Irrit. 2
Repr. 2
Aquatic Chronic 2
|
Notified C&L | View details |
2-(1,1-dimethylethyl)-6-[[3-(1,1-dimethylethyl)-2-hydroxy-5-methylphenyl]methyl]-4-methylphenyl acrylate
|
262-634-6 | 61167-58-6 |
Not Classified
|
REACH registration C&L | View details |
Nuclease, deoxyribo-
|
232-667-0 | 9003-98-9 |
Resp. Sens. 1
|
REACH registration C&L | View details |
4-decyloxazolidin-2-one 4-decyl-1,3-oxazolidin-2-one
613-314-00-3
|
443-770-7 | 7693-82-5 |
Aquatic Acute 1
Aquatic Chronic 1
|
Harmonised C&L | View details |
Aluminium hydroxide sulphate
|
215-573-4 | 1332-73-6 |
Eye Dam. 1
|
Notified C&L | View details |
Propyl isovalerate
|
209-148-2 | 557-00-6 |
Flam. Liq. 3
|
Notified C&L | View details |
4-(aminomethyl)benzonitrile
|
233-877-5 | 10406-25-4 |
Acute Tox. 4
|
Notified C&L | View details |
Guanine
|
200-799-8 | 73-40-5 |
Skin Irrit. 2
Eye Irrit. 2
|
REACH registration C&L | View details |
4-ethyltoluene
|
210-761-2 | 622-96-8 |
Flam. Liq. 3
Asp. Tox. 1
|
Notified C&L | View details |
Carbamic acid, butyl ester, polymer with formaldehyde
|
608-021-2 | 26935-10-4 |
Not Classified
|
Notified C&L | View details |
PIGMENT RED 5021B
|
410-210-8 |
Not Classified
|
Notified C&L | View details | |
Fatty acids, C14-18 and C16-18-unsatd., ethoxylated (9-EO)
|
614-330-3 | 68154-25-6 |
Aquatic Chronic 4
|
Notified C&L | View details |
Bis(4-octylphenyl)amine
|
202-965-5 | 101-67-7 |
Aquatic Chronic 2
|
Notified C&L | View details |
Safflower oil
Extractives and their physically modified derivatives. It consists primarily of the glycerides of the fatty acid linoleic. (Carthamus tinctorius, Compositae).
|
232-276-5 | 8001-23-8 |
Not Classified
|
Notified C&L | View details |
Origanum compactum, ext.
|
290-114-9 | 90082-26-1 |
Acute Tox. 4
Asp. Tox. 1
Skin Corr. 1C
Skin Sens. 1
Eye Dam. 1
Aquatic Chronic 3
|
Notified C&L | View details |
6-bromo-2-naphthyl β-D-glucopyranosiduronic acid
|
245-176-1 | 22720-35-0 |
Not Classified
|
Notified C&L | View details |
Trichlorocyclopentylsilane
|
238-621-6 | 14579-03-4 |
Skin Corr. 1A
Eye Dam. 1
|
REACH registration C&L | View details |
Calcium L-aspartate
|
244-185-8 | 21059-46-1 |
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
STOT SE 3
|
Notified C&L | View details |
Pentasodium triphosphate
|
231-838-7 | 7758-29-4 |
Not Classified
|
REACH registration C&L | View details |
Pentafluorobenzene
|
206-658-7 | 363-72-4 |
Flam. Liq. 2
Acute Tox. 4
|
Notified C&L | View details |
Trichloropentylsilane
|
203-515-0 | 107-72-2 |
Flam. Liq. 3
Acute Tox. 3
Skin Corr. 1B
Acute Tox. 3
|
Notified C&L | View details |
Sodium tetradecyl sulfate
|
205-380-3 | 139-88-8 |
Acute Tox. 4
Acute Tox. 3
Skin Corr. 1B
|
Notified C&L | View details |
β-methylstyrene
|
211-287-9 | 637-50-3 |
Flam. Liq. 2
|
Notified C&L | View details |
Reaction mass of 8,18-dichloro-5,15-diethyl-5,15-dihydro-N,N'-bis[3-(2-methylpiperidino)propyl]-7,17-dioxa-5,9,15,19-tetraazadiindeno[1,2-b:1',2'-m]pentacene disulfonamide and 8-chloro-5,15-diethyl-5,15-dihydro-N,N'-bis[3-(2-methylpiperidino)propyl]-7,17-dioxa-5,9,15,19-tetraazadiindeno[1,2-b:1',2'-m]pentacene disulfonamide
|
426-570-4 | 186614-87-9 |
Skin Sens. 1
Eye Irrit. 2
|
Notified C&L | View details |
Trisodium citrate
|
200-675-3 | 68-04-2 |
Not Classified
|
REACH registration C&L | View details |
2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium acetate
|
264-796-3 | 64346-30-1 |
Acute Tox. 3
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
REACH registration C&L | View details |
2-benzyl 1-tert-butyl (2S)-5-oxopyrrolidine-1,2-dicarboxylate
|
601-251-4 | 113400-36-5 |
Skin Irrit. 2
Eye Irrit. 2A
STOT SE 3
|
Notified C&L | View details |
2-amino-N,N-dipropylacetamide;hydrochloride
|
601-023-4 | 11099-03-9 |
Not Classified
|
Notified C&L | View details |
1-[4-[[6-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2-hydroxy-6-methoxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-one
|
246-128-2 | 24292-52-2 |
Not Classified
|
Notified C&L | View details |
tert-butylarsine
TERTIARYBUTYLARSINE; TERTIÄRBUTYLARSIN
033-007-00-2
|
423-320-6 | 4262-43-5 |
Pyr. Liq. 1
Acute Tox. 2
|
Harmonised C&L | View details |
C.I. DIRECT RED 89
|
601-899-8 | 12217-67-3 |
Not Classified
|
Notified C&L | View details |
tolclofos-methyl (ISO);
O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate
015-113-00-0
|
260-515-3 | 57018-04-9 |
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
|
Harmonised C&L | View details |
4,5-dichloro-2-nitroaniline
|
229-657-3 | 6641-64-1 |
Acute Tox. 2
Acute Tox. 1
Acute Tox. 2
STOT RE 2
STOT RE 2
Aquatic Chronic 2
|
Notified C&L | View details |
2,3-dibromopropyl acrylate
|
243-208-9 | 19660-16-3 |
Skin Irrit. 2
Eye Irrit. 2
|
Notified C&L | View details |
Ethyl hex-3-enoate
|
219-257-7 | 2396-83-0 |
Flam. Liq. 3
|
Notified C&L | View details |
Anthemis nobilis, ext.
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Anthemis nobilis, Compositae.
|
283-467-5 | 84649-86-5 |
Flam. Liq. 3
Asp. Tox. 1
Skin Sens. 1
Aquatic Chronic 2
|
Notified C&L | View details |
Fatty acids, C12-20
|
269-807-5 | 68334-02-1 |
Not Classified
|
Notified C&L | View details |
Hydrocarbons, C20-58, hydrotreated Baseoil - unspecified
649-523-00-1
|
308-289-8 | 97926-70-0 |
Carc. 1B
|
Harmonised C&L | View details |
trans-2-isopropyl-5-carboxy-1,3-dioxane
DHP OPT
607-668-00-8
|
445-770-2 | 42031-28-7 |
Eye Dam. 1
Aquatic Chronic 3
|
Harmonised C&L | View details |
Nona-2-6-dienenitrile
|
266-545-3 | 67019-89-0 |
Not Classified
|
Notified C&L | View details |